Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease

English version České info

Genetic prion diseases are degenerative brain disorders caused by mutations in the gene encoding the prion protein (PrP). Different PrP mutations cause different diseases, including Creutzfeldt-Jakob disease (CJD) and fatal familial insomnia (FFI). The reason for this variability is not known, but assembly of the mutant PrPs into distinct aggregates that spread in the brain by promoting PrP aggregation may contribute to the disease phenotype. We previously generated transgenic mice modeling genetic CJD, clinically identified by dementia and motor abnormalities. We have now generated transgenic mice carrying the PrP mutation associated with FFI, and found that they develop severe sleep abnormalities and other key features of the human disorder. Thus, transgenic mice recapitulate the phenotypic differences seen in humans. The mutant PrPs in FFI and CJD mice are aggregated but unable to promote PrP aggregation. They accumulate in different intracellular compartments and cause distinct morphological abnormalities of transport organelles. These results indicate that mutant PrP has disease-encoding properties that are independent of its ability to self-propagate, and suggest that the phenotypic heterogeneity may be due to different effects of aggregated PrP on intracellular transport. Our study provides new insights into the mechanisms of selective neuronal dysfunction due to protein aggregation.

Vyšlo v časopise: Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease. PLoS Pathog 11(4): e32767. doi:10.1371/journal.ppat.1004796
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004796

Souhrn

Zdroje

1. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–50. Epub 2001/04/03. doi: 10.1146/annurev.neuro.24.1.519 24/1/519 [pii]. 11283320

2. Watts JC, Balachandran A, Westaway D. The expanding universe of prion diseases. PLoS Pathog. 2006;2(3):e26. Epub 2006/04/13. doi: 10.1371/journal.ppat.0020026. 16609731

3. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66:255–65. Epub 2003/10/03. 14522863

4. Brown P, Gibbs CJ Jr., Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35(5):513–29. Epub 1994/05/01. doi: 10.1002/ana.410350504. 8179297

5. Colby DW, Prusiner SB. De novo generation of prion strains. Nat Rev Microbiol. 2011;9(11):771–7. Epub 2011/09/29. nrmicro2650 [pii]doi: 10.1038/nrmicro2650. 21947062

6. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136–44. Epub 1982/04/09. 6801762

7. Mastrianni JA. The genetics of prion diseases. Genet Med. 2010;12(4):187–95. Epub 2010/03/11. doi: 10.1097/GIM.0b013e3181cd7374. 20216075

8. Mead S, Reilly MM. A new prion disease: relationship with central and peripheral amyloidoses. Nat Rev Neurol. 2015. Epub 2015/01/28. nrneurol.2014.263 [pii]doi: 10.1038/nrneurol.2014.263.

9. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258(5083):806–8. Epub 1992/10/30. 1439789

10. Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wuthrich K. Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci U S A. 1998;95(20):11667–72. Epub 1998/09/30. 9751723

11. Apetri AC, Vanik DL, Surewicz WK. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90–231. Biochemistry. 2005;44(48):15880–8. Epub 2005/11/30. doi: 10.1021/bi051455+. 16313190

12. Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, Surewicz WK, et al. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J. 2010;29(1):251–62. Epub 2009/11/21. emboj2009333 [pii] doi: 10.1038/emboj.2009.333. 19927125

13. Chiesa R, Piccardo P, Ghetti B, Harris DA. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron. 1998;21(6):1339–51. Epub 1999/01/12. S0896-6273(00)80653-4 [pii]. 9883727

14. Dossena S, Imeri L, Mangieri M, Garofoli A, Ferrari L, Senatore A, et al. Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron. 2008;60(4):598–609. Epub 2008/11/29. S0896-6273(08)00755-1 [pii] doi: 10.1016/j.neuron.2008.09.008. 19038218

15. Senatore A, Colleoni S, Verderio C, Restelli E, Morini R, Condliffe SB, et al. Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α2δ-1 subunit. Neuron. 2012;74(2):300–13. Epub 2012/05/01. S0896-6273(12)00235-8 [pii] doi: 10.1016/j.neuron.2012.02.027. 22542184

16. Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A. 1994;91(7):2839–42. Epub 1994/03/29. 7908444

17. Borbely AA. A two process model of sleep regulation. Hum Neurobiol. 1982;1(3):195–204. Epub 1982/01/01. 7185792

18. Amici R, Cerri M, Ocampo-Garces A, Baracchi F, Dentico D, Jones CA, et al. Cold exposure and sleep in the rat: REM sleep homeostasis and body size. Sleep. 2008;31(5):708–15. Epub 2008/06/04. 18517040

19. Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B, et al. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A. 2000;97(10):5574–9. Epub 2000/05/11. 97/10/5574 [pii]. 10805813

20. Nazor KE, Kuhn F, Seward T, Green M, Zwald D, Purro M, et al. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J. 2005;24(13):2472–80. Epub 2005/06/18. 7600717 [pii]doi: 10.1038/sj.emboj.7600717. 15962001

21. Torres JM, Castilla J, Pintado B, Gutierrez-Adan A, Andreoletti O, Aguilar-Calvo P, et al. Spontaneous generation of infectious prion disease in transgenic mice. Emerg Infect Dis. 2013;19(12):1938–47. Epub 2013/11/28. doi: 10.3201/eid1912.130106. 24274622

22. Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, et al. First experimental transmission of fatal familial insomnia. Nature. 1995;376(6539):434–5. Epub 1995/08/03. doi: 10.1038/376434a0. 7630420

23. Brown P, Goldfarb LG, Kovanen J, Haltia M, Cathala F, Sulima M, et al. Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol. 1992;31(3):282–5. Epub 1992/03/11. doi: 10.1002/ana.410310309. 1353342

24. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 1996;274(5295):2079–82. Epub 1996/12/20. 8953038

25. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, Oesch B, et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 1996;15(6):1255–64. Epub 1996/03/15. 8635458

26. Chiesa R, Piccardo P, Quaglio E, Drisaldi B, Si-Hoe SL, Takao M, et al. Molecular distinction between pathogenic and infectious properties of the prion protein. J Virol. 2003;77(13):7611–22. Epub 2003/06/14. 12805461

27. Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol. 2010;68(2):162–72. Epub 2010/08/10. doi: 10.1002/ana.22094. 20695009

28. Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Ostapchenko VG, Budka H, et al. A new mechanism for transmissible prion diseases. J Neurosci. 2012;32(21):7345–55. Epub 2012/05/25. 32/21/7345 [pii]doi: 10.1523/JNEUROSCI.6351-11.2012. 22623680

29. Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell. 2005;121(2):195–206. Epub 2005/04/27. S0092-8674(05)00156-X [pii]doi: 10.1016/j.cell.2005.02.011. 15851027

30. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 1990;63(4):673–86. Epub 1990/11/16. 0092-8674(90)90134-Z [pii]. 1977523

31. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A. 2000;97(18):10248–53. 10963685

32. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol. 2003;2(3):167–76. Epub 2003/07/10. S1474442203003235 [pii]. 12849238

33. Sforza E, Montagna P, Tinuper P, Cortelli P, Avoni P, Ferrillo F, et al. Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. Electroencephalogr Clin Neurophysiol. 1995;94(6):398–405. Epub 1995/06/01. 001346949400318F [pii]. 7607093

34. Tinuper P, Montagna P, Medori R, Cortelli P, Zucconi M, Baruzzi A, et al. The thalamus participates in the regulation of the sleep-waking cycle. A clinico-pathological study in fatal familial thalamic degeneration. Electroencephalogr Clin Neurophysiol. 1989;73(2):117–23. Epub 1989/08/01. 2473878

35. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature. 1996;380(6575):639–42. Epub 1996/04/18. doi: 10.1038/380639a0. 8602267

36. Manetto V, Medori R, Cortelli P, Montagna P, Tinuper P, Baruzzi A, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology. 1992;42(2):312–9. Epub 1992/02/01. 1736158

37. Taniwaki Y, Hara H, Doh-Ura K, Murakami I, Tashiro H, Yamasaki T, et al. Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia. J Neurol Neurosurg Psychiatry. 2000;68(3):388. Epub 2000/04/29. 10787306

38. McLean CA, Storey E, Gardner RJ, Tannenberg AE, Cervenakova L, Brown P. The D178N (cis-129M) "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology. 1997;49(2):552–8. Epub 1997/08/01. 9270595

39. Zerr I, Giese A, Windl O, Kropp S, Schulz-Schaeffer W, Riedemann C, et al. Phenotypic variability in fatal familial insomnia (D178N-129M) genotype. Neurology. 1998;51(5):1398–405. Epub 1998/11/18. 9818868

40. Almer G, Hainfellner JA, Brucke T, Jellinger K, Kleinert R, Bayer G, et al. Fatal familial insomnia: a new Austrian family. Brain. 1999;122 (Pt 1):5–16. Epub 1999/03/02. 10050890

41. Jackson WS, Borkowski AW, Faas H, Steele AD, King OD, Watson N, et al. Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron. 2009;63(4):438–50. Epub 2009/08/28. S0896-6273(09)00581-9 [pii]doi: 10.1016/j.neuron.2009.07.026. 19709627

42. Chiesa R, Piccardo P, Biasini E, Ghetti B, Harris DA. Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. J Neurosci. 2008;28(49):13258–67. Epub 2008/12/05. 28/49/13258 [pii]doi: 10.1523/JNEUROSCI.3109-08.2008. 19052217

43. Friedman-Levi Y, Mizrahi M, Frid K, Binyamin O, Gabizon R. PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease. PLoS One. 2013;8(7):e69583. Epub 2013/08/08. doi: 10.1371/journal.pone.0069583PONE-D-13-18821 [pii]. 23922744

44. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, et al. Prion protein is necessary for normal synaptic function. Nature. 1994;370(6487):295–7. Epub 1994/07/28. doi: 10.1038/370295a0. 8035877

45. Krasnianski A, Bartl M, Sanchez Juan PJ, Heinemann U, Meissner B, Varges D, et al. Fatal familial insomnia: clinical features and early identification. Ann Neurol. 2008;63(5):658–61. Epub 2008/03/25. doi: 10.1002/ana.21358. 18360821

46. Macchi G, Rossi G, Abbamondi AL, Giaccone G, Mancia D, Tagliavini F, et al. Diffuse thalamic degeneration in fatal familial insomnia. A morphometric study. Brain Res. 1997;771(1):154–8. Epub 1998/02/12. S0006-8993(97)00902-5 [pii]. 9383019

47. Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol. 1995;38(1):21–9. Epub 1995/07/01. doi: 10.1002/ana.410380107. 7611720

48. Biasini E, Seegulam ME, Patti BN, Solforosi L, Medrano AZ, Christensen HM, et al. Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies. J Neurochem. 2008;105(6):2190–204. Epub 2008/02/27. JNC5306 [pii]doi: 10.1111/j.1471-4159.2008.05306.x. 18298665

49. Tapella L, Stravalaci M, Bastone A, Biasini E, Gobbi M, Chiesa R. Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases. Biochem J. 2013;454(3):417–25. Epub 2013/07/03. BJ20130563 [pii] doi: 10.1042/BJ20130563. 23808898

50. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A. 2009;106(1):304–9. Epub 2008/12/17. 0810680105 [pii]doi: 10.1073/pnas.0810680105. 19073920

51. Stohr J, Watts JC, Legname G, Oehler A, Lemus A, Nguyen HO, et al. Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci U S A. 2011;108(52):21223–8. Epub 2011/12/14. 1117827108 [pii]doi: 10.1073/pnas.1117827108. 22160704

52. Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG, Budka H, et al. Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathog. 2011;7(11):e1002350. Epub 2011/11/11. doi: 10.1371/journal.ppat.1002350 PPATHOGENS-D-11-01077 [pii]. 22072968

53. Watts JC, Giles K, Stohr J, Oehler A, Bhardwaj S, Grillo SK, et al. Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A. 2012;109(9):3498–503. Epub 2012/02/15. 1121556109 [pii] doi: 10.1073/pnas.1121556109. 22331873

54. Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 1999;18(23):6855–64. Epub 1999/12/03. doi: 10.1093/emboj/18.23.6855. 10581259

55. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 1995;83(1):79–90. Epub 1995/10/06. 0092-8674(95)90236-8 [pii]. 7553876

56. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, et al. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A. 2012;109(22):8546–51. Epub 2012/05/16. 1204498109 [pii] doi: 10.1073/pnas.1204498109. 22586108

57. Biasini E, Medrano AZ, Thellung S, Chiesa R, Harris DA. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion. J Neurochem. 2008;104(5):1293–308. Epub 2007/11/24. JNC5082 [pii] doi: 10.1111/j.1471-4159.2007.05082.x. 18034781

58. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature. 1995;375(6533):698–700. Epub 1995/06/22. doi: 10.1038/375698a0. 7791905

59. Yang W, Cook J, Rassbach B, Lemus A, DeArmond SJ, Mastrianni JA. A new transgenic mouse model of Gerstmann-Sträussler-Scheinker syndrome caused by the A117V mutation of PRNP. J Neurosci. 2009;29(32):10072–80. Epub 2009/08/14. 29/32/10072 [pii] doi: 10.1523/JNEUROSCI.2542-09.2009. 19675240

60. Chiesa R, Harris DA. Prion diseases: what is the neurotoxic molecule? Neurobiol Dis. 2001;8(5):743–63. Epub 2001/10/11. doi: 10.1006/nbdi.2001.0433 S0969-9961(01)90433-4 [pii]. 11592845

61. Chiesa R. The elusive role of the prion protein and the mechanism of toxicity in prion disease. PLoS Pathog. 2015; In press.

62. Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501(7465):45–51. Epub 2013/09/06. nature12481 [pii] doi: 10.1038/nature12481. 24005412

63. Mallucci G. Spreading proteins in neurodegeneration: where do they take us? Brain. 2013;136(Pt 4):994–5. Epub 2013/03/23. awt072 [pii] doi: 10.1093/brain/awt072. 23518708

64. Drisaldi B, Stewart RS, Adles C, Stewart LR, Quaglio E, Biasini E, et al. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem. 2003;278(24):21732–43. Epub 2003/03/29. doi: 10.1074/jbc.M213247200 M213247200 [pii]. 12663673

65. Fioriti L, Dossena S, Stewart LR, Stewart RS, Harris DA, Forloni G, et al. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J Biol Chem. 2005;280(12):11320–8. Epub 2005/01/06. M412441200 [pii] doi: 10.1074/jbc.M412441200. 15632159

66. Quaglio E, Restelli E, Garofoli A, Dossena S, De Luigi A, Tagliavacca L, et al. Expression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunction. PLoS One. 2011;6(4):e19339. Epub 2011/05/12. doi: 10.1371/journal.pone.0019339 PONE-D-11-01260 [pii]. 21559407

67. Massignan T, Biasini E, Lauranzano E, Veglianese P, Pignataro M, Fioriti L, et al. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway. Mol Cell Proteomics. 2010;9(4):611–22. Epub 2009/12/10. M900271-MCP200 [pii] doi: 10.1074/mcp.M900271-MCP200. 19996123

68. Daude N, Lehmann S, Harris DA. Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J Biol Chem. 1997;272(17):11604–12. Epub 1997/04/25. 9111077

69. Biasini E, Tapella L, Restelli E, Pozzoli M, Massignan T, Chiesa R. The hydrophobic core region governs mutant prion protein aggregation and intracellular retention. Biochem J. 2010;430(3):477–86. Epub 2010/07/16. BJ20100615 [pii] doi: 10.1042/BJ20100615. 20626348

70. Senatore A, Restelli E, Chiesa R. Synaptic dysfunction in prion diseases: a trafficking problem? Int J Cell Biol. 2013;2013:543803. Epub 2013/12/27. doi: 10.1155/2013/543803. 24369467

71. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol. 2008;181(3):551–65. Epub 2008/04/30. jcb.200711002 [pii] doi: 10.1083/jcb.200711002. 18443219

72. You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, et al. Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A. 2012;109(5):1737–42. Epub 2012/02/07. 1110789109 [pii] doi: 10.1073/pnas.1110789109. 22307640

73. Watt NT, Taylor DR, Kerrigan TL, Griffiths HH, Rushworth JV, Whitehouse IJ, et al. Prion protein facilitates uptake of zinc into neuronal cells. Nat Commun. 2012;3:1134. Epub 2012/10/18. ncomms2135 [pii] doi: 10.1038/ncomms2135. 23072804

74. Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol. 2007;23:613–43. Epub 2007/05/18. doi: 10.1146/annurev.cellbio.23.090506.123516. 17506699

75. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62(3):405–96. Epub 2010/08/19. 62/3/405 [pii] doi: 10.1124/pr.109.002451. 20716669

76. Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, et al. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal. 1996;13(6):159–63. Epub 1996/12/01. 9117892

77. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992;356(6370):577–82. Epub 1992/04/16. doi: 10.1038/356577a0. 1373228

78. Baracchi F, Opp MR. Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1. Brain Behav Immun. 2008;22(6):982–93. Epub 2008/03/11. S0889-1591(08)00040-8 [pii] doi: 10.1016/j.bbi.2008.02.001. 18329246

79. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. Epub 2012/06/30. nmeth.2019 [pii] doi: 10.1038/nmeth.2019. 22743772

80. Giaccone G, Canciani B, Puoti G, Rossi G, Goffredo D, Iussich S, et al. Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. Brain Pathol. 2000;10(1):31–7. Epub 2000/02/11. 10668893

81. Beznoussenko GV, Dolgikh VV, Seliverstova EV, Semenov PB, Tokarev YS, Trucco A, et al. Analogs of the Golgi complex in microsporidia: structure and avesicular mechanisms of function. J Cell Sci. 2007;120(Pt 7):1288–98. Epub 2007/03/16. jcs.03402 [pii] doi: 10.1242/jcs.03402. 17356068

82. Saa P, Castilla J, Soto C. Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol. 2005;299:53–65. Epub 2005/06/28. 1-59259-874-9:053 [pii]. 15980595